These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36938587)

  • 1. Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.
    Wright JJ; Dulaney A; Williams JM; Hilmes MA; Du L; Kang H; Powers AC; Moore DJ; Virostko J
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2699-2707. PubMed ID: 36938587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset.
    Virostko J; Williams J; Hilmes M; Bowman C; Wright JJ; Du L; Kang H; Russell WE; Powers AC; Moore DJ
    Diabetes Care; 2019 Feb; 42(2):248-257. PubMed ID: 30552135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    Virostko J; Hilmes M; Eitel K; Moore DJ; Powers AC
    PLoS One; 2016; 11(7):e0158825. PubMed ID: 27391588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 5. Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.
    Virostko J; Wright JJ; Williams JM; Hilmes MA; Triolo TM; Broncucia H; Du L; Kang H; Nallaparaju S; Valencia LG; Reyes D; Hammel B; Russell WE; Philipson LH; Waibel M; Kay TWH; Thomas HE; Greeley SAW; Steck AK; Powers AC; Moore DJ
    Diabetes Care; 2024 Mar; 47(3):393-400. PubMed ID: 38151474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
    Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
    Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-based pancreas volume assessment in individuals with type 1 diabetes.
    Roger R; Hilmes MA; Williams JM; Moore DJ; Powers AC; Craddock RC; Virostko J
    BMC Med Imaging; 2022 Jan; 22(1):5. PubMed ID: 34986790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation.
    Dadlani V; Kaur RJ; Stegall M; Xyda SE; Kumari K; Bonner K; Smith B; Thapa P; Dean PG; Kudva YC
    Clin Transplant; 2019 Oct; 33(10):e13719. PubMed ID: 31545535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
    Sherr J; Tamborlane WV; Xing D; Tsalikian E; Mauras N; Buckingham B; White NH; Arbelaez AM; Beck RW; Kollman C; Ruedy K;
    Diabetes Care; 2012 Apr; 35(4):817-20. PubMed ID: 22323414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
    Juel CTB; Dejgaard TF; Hansen CP; Storkholm JH; Vilsbøll T; Lund A; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(1):168-173. PubMed ID: 33053154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
    Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
    Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatability and Reproducibility of Pancreas Volume Measurements Using MRI.
    Williams JM; Hilmes MA; Archer B; Dulaney A; Du L; Kang H; Russell WE; Powers AC; Moore DJ; Virostko J
    Sci Rep; 2020 Mar; 10(1):4767. PubMed ID: 32179809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study.
    Charleer S; Mathieu C; Nobels F; De Block C; Radermecker RP; Hermans MP; Taes Y; Vercammen C; T'Sjoen G; Crenier L; Fieuws S; Keymeulen B; Gillard P;
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1224-1232. PubMed ID: 29342264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.
    Shah VN; DuBose SN; Li Z; Beck RW; Peters AL; Weinstock RS; Kruger D; Tansey M; Sparling D; Woerner S; Vendrame F; Bergenstal R; Tamborlane WV; Watson SE; Sherr J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4356-4364. PubMed ID: 31127824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.